SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " BIO " 2,824 found 🔀 AI-powered Shuffle
Cruz Foam had a promising idea. Why couldn’t it make its sustainable packaging business work?
Cruz Foam's biodegradable packing material made from shrimp shells and food waste attracted wide attention and big-name investors, but the Santa Cruz-based company has closed up shop after what one former exec says were struggles to solve the full range of problems its customers needed packaging to address.
This week in Santa Cruz County business: Cruz Foam ceases operations; West Coast Community Bank celebrates Nasdaq listing
Santa Cruz-based Cruz Foam, which developed a biodegradable packaging made from shrimp shells and other natural materials, has closed and sold off its intellectual property, Jessica M. Pasko reports in her weekly look at local business. Meanwhile, Santa Cruz-based West Coast Community Bancorp has moved its stock listing to the Nasdaq Stock Market, a milestone executives say is more than two decades in the making.
Marco Rubio and President Mirziyoyev Highlight U.S.–Uzbekistan Economic Cooperation at Business and Investment Council
To publish news and commentary - without fear or favor - in the finest tradition of independent journalism
Research report: Digital Science and Sunmedia partner to bring research impact reporting to Japan’s medical affairs teams
Sunmedia will use Dimensions and Altmetric data in customized reports intended to assess attention, sentiment and real-world connections for Japanese medical affairs teams.
UAB opens Shelby Biosciences Research Building to advance health
UAB has opened the Shelby Biosciences Research Building, an eight-story facility named after former U.S. Sen. Richard Shelby, aimed at supporting health research and creating new jobs.
How a photo of a person’s face could help predict whether they’ll survive cancer treatment
A simple selfie could hold surprising clues to your overall health and longevity, especially among people with cancer.
New Richland Lab Could Transform How Scientists Study Microbes and Boost Regional Jobs
The BriefGroundbreaking held Tuesday: PNNL officially began construction on the M2PC lab, a 30,800-square-foot facility funded by the U.S. Department of Energy's Office of Science that will study soil microbes to improve crop productivity and develop new biotechnology applications. The facility will be open to researchers from around the nation and the world.Research timelines could shrink dramatically: The facility's automation and AI capabilities could reduce experiments that currently take six months to just 72 hours, allowing scientists to explore more possibilities faster than ever before.New jobs coming to the Tri-Cities: The project is expected to create positions for automation engineers, AI experts, roboticists, technicians, and skilled craftspeople, with the facility opening in 2029.RICHLAND, Wash. — Pacific Northwest National Laboratory broke ground Tuesday on a first-of-its-kind facility that could accelerate scientific discoveries about the microscopic organisms living in soil—organisms that may hold the key to growing more food and developing new energy technologies.The Microbial Molecular Phenotyping Capability, or M2PC, represents a significant investment in automation and artificial intelligence to speed up research that traditionally takes years to complete. The 30,800-square-foot facility will house more than 100 connected automated instruments designed to study microbes at a pace and scale never before possible.Reshaping Agriculture's FutureThe M2PC facility will not put a new tool directly into a farmer's hands tomorrow morning, but it is actively reshaping the commercial pipeline to solve agriculture's biggest headache with biologicals: inconsistent field performance. For years, PNNL researchers have explored how microbes work and how they might help produce useful materials, advance energy technologies, and address challenges involving critical materials and minerals. But those experiments have been limited by what researchers could accomplish by hand."They can be used to provide nutrients to a plant so that the plant would grow more. So, like increasing your crop productivity, for example," said Douglas Mans, PNNL's Associate Laboratory Director for Integrated Discovery Sciences.PNNL's own research shows soil microbes can help plants access nutrients and withstand drought—benefits that could prove crucial as farmers face growing environmental pressures. The M2PC facility will allow scientists to identify and optimize useful microbes faster than ever before, accelerating the development of biological solutions that actually work consistently in the field.What Makes M2PC UniqueThe Microbial Molecular Phenotyping Capability differs from traditional research labs because it operates as a first-of-its-kind, AI-enabled autonomous laboratory designed to shrink experimental timelines from years down to months or weeks. The M2PC lab will connect more than 100 automated instruments to grow microbes, prepare samples, measure their behavior, and link observations to the molecular processes behind them. Artificial intelligence will help analyze results and guide the next experiments, allowing scientists to explore more questions faster.Deb Gracio, PNNL Director, emphasized the transformative potential during Tuesday's groundbreaking ceremony: "Research that has taken years will become possible in months and hopefully in weeks."That acceleration is already being demonstrated. PNNL's smaller automated lab, called the Anaerobic Microbial Phenotyping Platform or AMP2, completed three experimental cycles in just 72 hours—a process that normally would have taken about six months."That normally would have taken us about six months … and we were able to do that in 72 hours," Mans said.The AMP2 laboratory is not being closed or replaced. Instead, the current 1,800-square-foot laboratory serves as an active prototype and precursor for the much larger M2PC facility. AMP2 will continue operating as a separate lab designed to run anaerobic experiments—those conducted in the absence of oxygen—while M2PC will focus on aerobic research.Broader Applications Beyond AgricultureWhile improving crop productivity is one important application, the M2PC facility is designed to support research into multiple areas critical to national priorities. The lab will advance research into biofuels, manufacturing materials, and energy technologies. It will also help researchers understand how microbes respond to environmental changes and how to design biological systems for biotechnology applications.As a flagship component of the Department of Energy's Genesis Mission, M2PC represents a significant investment in using artificial intelligence and automation to accelerate U.S. scientific discovery. Dorothy Koch, Associate Director of the DOE Office of Science Biological and Environmental Research program, highlighted the facility's importance during the groundbreaking."M2PC will accelerate biological discovery and design," Koch said, noting that the facility is expected to conduct a minimum of 500 strain experiments per week, 100 microbiome experiments per week, and take a million measurements per month.Economic Opportunity for the RegionBeyond the scientific breakthroughs, the M2PC project represents significant economic opportunity for the Tri-Cities region. The facility will require hiring automation engineers, AI experts, technicians skilled in operating robotics, and specialized craftspeople to build and maintain the sophisticated equipment."We're anticipating that type of hiring," Mans said when asked about job creation.PNNL has already begun recruiting talent nationally and internationally for positions related to the smaller AMP2 lab, bringing automation engineers from cities like Boston and San Francisco to work in the region. The M2PC facility is expected to accelerate that trend."This capability won't really exist anywhere else in the world," Mans said, suggesting the facility could become a draw for scientific talent seeking to work on cutting-edge biotechnology research.Timeline and Next StepsThe M2PC facility is expected to open in 2029. Between now and then, construction crews will level and prepare the ground, while the building takes shape. Simultaneously, Ginkgo Bio Works, the automation contractor, will build the facility's automation components off-site so they can be installed as the building is completed.In the interim, PNNL researchers and the broader scientific community will begin planning the first experiments to be conducted in the facility, ensuring research is lined up and ready to begin as soon as the doors open.The groundbreaking ceremony included representatives from the Department of Energy, PNNL leadership, and elected officials at the federal, state, and local levels, underscoring the project's significance to the region and the nation's biotechnology future. News The U.S. Department of Energy Secretary tours Pacific Northwest National Laboratory Dan Hanson, Apple Valley News Now News Beyond DNA: Scientists Explore New Frontiers in Biology Research Dan Hanson, Apple Valley News Now News TRIDEC optimistic that Hanford, PNNL will see funding in national budget Robert Desaulniers News Big picture science: monitoring the Yakima River Basin News PNNL research could shape the future of fighting fentanyl COPYRIGHT 2026 BY APPLE VALLEY NEWS NOW. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.
Scientists Use Ancient Rains to Map the Possible Origin Life on Mars
Billions of years ago, rain may have helped shape where the chemistry of life could begin on Mars. A new study maps how formaldehyde, an important prebiotic molecule, may have reached the surface. This map could help guide future missions searching for signs of past life on Mars.
OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
/PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...
Scientists Say Honey Bee Colonies Are Superorganisms and We've Been Understanding Them All Wrong
A radical rethink of honey bee biology challenges how scientists understand swarming and even beekeeping.
Guardant Health to Highlight Advances in Liquid Biopsy for Cancer Monitoring at ESMO 2026
Guardant Health and partners will present 25 abstracts on liquid biopsy advances for cancer monitoring at ESMO 2026.
Understanding Intelligence Across Artificial and Biological Systems
Recently I started a new peer-reviewed journal at the crossroads of Artificial Intelligence and Cognition research. The journal, titled "AI and Brain", is published by Scilight Press, a young
Prenosis and Carle Health Mark Sepsis ImmunoScore® Clinical Deployment and First Patients Enrolled in OBSERVE-ARDS Clinical Study
/PRNewswire/ -- Prenosis®, a biology-based technology company delivering precision therapeutics, today announced three milestones in its ongoing relationship...
Life Science Connect Acquires BrevisRefero to Expand Biopharma Outsourcing Technology Capabilities
Life Science Connect (LSC) has acquired Toronto-based BrevisRefero Corporation, a biopharmaceutical consulting firm and developer of the RFP>Navigator® platform, expanding... Read More
Could AI Use a Simple Photo of Your Face to Reveal Clues About Your Health?
A new AI model can estimate biological age and predict cancer survival outcomes using a simple photo of a patient’s face, though more research is needed before doctors will be able to use it to help them decide on treatments.
‘These risks are real’: the threat of AI bioweapons
In his annual speech on threats to the nation, Sir Ken McCallum, the head of the UK’s intelligence service, MI5, warned that AI had the potential to ‘change the stakes’ on existing and even new bioweapons. To find out why, and how, Ian Sample speaks to Dr Tom Inglesby, director of the Johns Hopkins Center for Health Security and the Bloomberg School of Public Health. He explains what has governments so worried and what measures could be put in place to reduce the risks
Start-Up Claims to Treat a Patient With A.I.-Created Viruses
Certain viruses attack bacteria and can sometimes clear antibiotic-resistant infections. Researchers said they had tailored a virus to attack one patient’s illness.
Biotech firm Colossal set to return extinct bird’s egg to New Zealand
The biotech firm trying to bring extinct species back to life, Colossal Biosciences Inc., will return an egg from the flightless moa to its native New Zealand.
Scientists get funding to tackle 'biosecurity threat'
A University of Surrey team is helping develop a vaccine against a bacteria affecting poultry.
Uzbekistan's $12bn business drive gathers pace during Rubio visit
The package covers railways, critical minerals, finance and technology, with major US firms involved. Uzbek President Mirziyoyev outlined measures to attract investors, while business executives told Euronews that commercial activity is growing.
The art of science: MU students make art inspired by biology, anthropology departments
HUNTINGTON — Some artists would get mad if someone drove over their artwork, but that wasn’t the case in Pullman Square on Friday evening.
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
Pfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this marks the end of the road for the asset. The Big Pharma had been evaluating the therapy, dubbed PF-06835375, in a phase 2 study of 61 patients with primary immune thrombocytopenia (ITP) that kicked off in 2022, according to the federal trials register. However, Pfizer confirmed to Fierce on Monday that this study had been terminated “due to a business decision.” “The decision to terminate the trial was not based on any safety concerns,” a spokesperson pointed out. At time of publication, PF-06835375 remained listed on Pfizer’s website for both ITP and lupus. A phase 1 study in lupus wrapped up in 2022, according to the trials database. ITP is an autoimmune disorder characterized by a low platelet count. Novartis was at one point evaluating its B-cell-depleting antibody ianalumab—recently approved as Fabhalta to treat immunoglobulin A nephropathy—as a potential treatment ITP. But the therapy struggled to demonstrate a benefit in the clinic for this indication. When contacted by Fierce, Pfizer wouldn’t confirm whether all work on PF-06835375 has been halted, and whether the company has any other plans to explore C-X-C chemokine receptor type 5 (CXCR5) as a mechanism. CXCR5 is found in blood cancers such as diffuse large B-cell lymphoma and mantle cell lymphoma chemokine receptor. However, there is little expression in normal tissue, which has led some drug developers to explore its potential. Vincerx Pharma had at one point been planning to take an anti-CXCR5 ADC into the clinic to treat B-cell malignancies, but that ambition was scrapped due to cash constraints. Where Big Pharma is placing its bets is one of the hot topics being discussed at Fierce Biotech's high-impact event in London next month. Find out more information and register by clicking on the banner below: [ ](https://qtxasset.com/quartz/qcloud5/media/image/where_big_pharma_is_placing_its_bets.png?VersionId=B8JrRbJ.pFUSK1pJgjeWHLGm_18RdLAy)
Lil Jon recalls learning man who raised him isn’t his biological father
The rapper writes about the experience in his new memoir, “I Only Shout So You Can Hear Me.”
Your age may not tell the whole story about how healthy you are
Researchers developed a five-factor Lifestyle Index assessing physical activity, BMI, smoking, sleep quality, and sexual satisfaction in 312 Swiss adults aged 35 to 65 years. Higher scores were modestly associated with younger bio-functional age, suggesting a relationship between combined lifestyle patterns and functional health, although the findings cannot establish causation.
Magnolia Heights students visit Northwest Mississippi Community College for science field trip
Students from Magnolia Heights explored biology and chemistry through campus labs and hands-on experiments, according to Northwest Mississippi Community College.
Advancing Women's Health to Improve Outcomes in All Phases of Life
The Executive Order (“EO”) makes it federal policy to prioritize turning women’s health research into better clinical care at every life stage, and it directs HHS, through NIH, to set up a new Women’s Health Division within 90 days. In coordination with the NIH Office of Research on Women’s Health, the Division will focus on, among other things, understudied women’s health conditions, greater inclusion of women and girls in clinical trials and grant recipients’ adherence to NIH's policy on sex as a biological variable. The EO also creates a White House Women’s Health Task Force, co-chaired by the Secretary of HHS and the Assistant to the President and Chief of Staff and composed of officials from other departments and agencies.
AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment
Mass General Brigham researchers trained a new AI foundation model on more than 40 million facial images, and used it to develop AI tools to estimate biological age and directly predict survival risk in patients with cancer
What Does a Human Heart Need to Grow? Scientists Found the Answer in a Bioprinted Model
Heart problems that babies are born with, called congenital heart defects, often begin developing early in pregnancy. Approximately three weeks after fertilization, the human heart is still a simple, straight tube of cells and, over the course of about five weeks, this tiny structure must undergo a remarkable transformation to reshape itself into the complex organ that eventually pumps blood throughout the body.
Arpit Davé on Using Tech to Deliver Greater Impact for Patients
Learn how BioMarin’s Chief Digital and Information Officer envisions using technology to accelerate innovation for people with rare genetic conditions.
Scientists Create “Super Ice” That’s 10 Times Stronger and Rivals Concrete in Strength
A new form of reinforced ice could offer an unconventional building material for extreme polar environments, although questions about its long-term durability remain. Scientists have developed a new form of ice that approaches the compressive strength of conventional concrete while resisting the sudden fractures that make ordinary ice so brittle. Known as BioPykrete, the material
Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
Ganglberger and colleagues assessed a deep learning model’s ability to derive brain health scores from electroencephalography data.
Hackers Exploit Plex2Shell Flaws to Install Crypto Miners and Linux Proxy Backdoor
Attackers exploit four Plex Media Server flaws chained as Plex2Shell to deploy XMRig miners and reverse proxy software after PoC release.
NQPI welcomes Professor Michael Held, strengthening connections between molecular biology and nanoscale materials research
The Nanoscale and Quantum Phenomena Institute (NQPI) at Ohio University welcomes Professor Michael Held as its newest faculty member.
Does your gut health predict a vaccine fever?
New research suggests your gut microbiome may influence whether you develop a fever after receiving a vaccination.
How a Monk, an Emperor, and Cave Beetles Built the Science of Underground Life
In the mid-nineteenth century, the study of life in caves was not the work of laboratories or universities but of monks, aristocrats, merchants, and soldiers, all bound together by the ambitions of an empire. A new historical study published in
Verily Health to Integrate PacBio HiFi Sequencing With Data Platform
The multi-year collaboration will link PacBio sequencing workflows to Verily Pre to support biomedical research and AI model training.
Paul Harris elected to National Academy of Medicine
Paul Harris, PhD, Professor of Biomedical Informatics at Vanderbilt Health, has been elected to the National Academy of Medicine (NAM).
In memoriam: Frank M. Ahern, teaching professor emeritus of biobehavioral health
The College of Health and Human Development is saddened to share the news that Frank Ahern, teaching professor emeritus of biobehavioral health, passed away last month. Ahern came to Penn State in 1983 as a senior research associate in the Department of Health Policy and Administration and went on to co-found the Department of Biobehavioral Health in 1991.
Pierre Sage to remain Crystal Palace manager, but…
Despite being thrashed 5-0 by Brighton & Hove Albion at the weekend, Pierre Sage is nevertheless expected to be given more time to prove himself as Crystal Palace manager, according to reports in The ...
Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
/PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative...
Whitlam would push Australian PM Albanese to go ‘bigger and bolder,’ biographer says
Albanese read the biography in office, calling its author to discuss Whitlam’s political mistakes as he encountered them.
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq:...
‘Clean’ energy, local costs: Advocates challenge bioenergy’s climate claims
Companies market wood pellets and hog biogas as climate solutions. Critics say neighbors are exposed to health risks and life quality issues.
From Nanochemistry to Smart Roads: The Multi-Scale Science Transforming Sustainable Pavements
A new Frontiers in Materials editorial maps how functional additives, multi-scale analysis, and machine learning are turning road construction into a quantifiably sustainable, data-driven discipline.
New Tools and Fresh Thinking Are Reshaping the Science of Addiction
A new Frontiers Research Topic argues that biosensors, longitudinal phenotyping, and transdiagnostic biomarkers are transforming addiction from a static label into a dynamic, mechanism-based science.
Novichok Nerve Agents: What Science Actually Knows About the Deadliest Weapons
A new review finds that while Novichok agents potently inhibit acetylcholinesterase and modern forensics can verify exposure, many claimed properties of these weapons remain unvalidated by experiments on authenticated compounds.
Microalgae could make a common antibiotic more effective
Scientists have turned microalgae into an unlikely drug-delivery vehicle, using it to boost the effectiveness of a common antibiotic.
Gut Microbiome and Aging: How Gut Bacteria Influence Health and Longevity
The gut microbiome changes with age, with microbial diversity and function varying according to health status, diet, lifestyle, and medication use. These changes are associated with inflammation and age-related diseases, but evidence that microbiome-targeted interventions extend human lifespan remains limited.
Four Tiny Snail Species New to Science Found on Limestone Karsts of Laos
Biodiversity surveys on Laos limestone karsts have revealed eight Alycaeinae micro land snail species, four of which are new to science, highlighting the urgent need to protect these overlooked ecosystems.
Your age may not tell the whole story about your health, but your blood could
Researchers analyzed plasma metabolites from 18,476 individuals aged 1 to 96 years and developed two metabolomic aging measures to assess biological aging, chronic disease, and mortality risk. Accelerated metabolomic aging was associated with greater risks of chronic disease and death, while a separate mortality-linked measure provided additional information about health status and disease burden beyond conventional clinical assessments.
Marshmallow Root’s Chemistry Revealed: The Science Behind an Ancient Cough Remedy
A new review in Pharmacia compiles the chemical compounds and pharmacological effects of Althaea officinalis, the marshmallow plant long used for coughs, wounds, and inflammation.
Rubio heads to Central Asia as some wonder if he's keeping the most pressing matters at a distance
This tour is intended to promote U.S. economic and security ties with Central and South Asia. But it has only tangential links to the Trump administration’s current main foreign policy dilemmas in the Middle East and with the Russia-Ukraine war.
New Tools Let Users Edit and Load Modified VBIOS on GeForce RTX GPUs Without Flashing
A developer who goes by Panchovix has released three tools that let NVIDIA GeForce RTX 50, RTX 40, and RTX 30-series owners run a modified VBIOS without writing anything to the card's flash chip. The first is a VBIOS editor for Windows and Linux that can change power limits, voltage ceilings,...
South Texas Health System (@stxhealthsystem)
2 likes, 1 comments - stxhealthsystem on October 18, 2026: "Put Your Skills at the Heart of Innovation: South Texas Health System is seeking skilled and dedicated Cardiac Cath Lab Technologists to join the cardiovascular teams at STHS Heart and STHS Edinburg. In this vital role, you’ll support advanced cardiac procedures, help deliver potentially lifesaving care and make a meaningful difference for patients when it matters most. Join a team committed to clinical excellence, innovation and compassionate care. Ready to take your career to the next level? Explore opportunities with the Rio Grande Valley’s largest integrated healthcare network. STHS offers competitive pay, comprehensive benefits and an increased sign-on bonus for qualified applicants. Ready to make your next career move? View current openings and apply at the link in our bio.".
Citizen Science Reveals New Rocky Mountain Mussel Population
A citizen science observation has led to the confirmation of a new subpopulation of the endangered Rocky Mountain Ridged Mussel in the Fraser River watershed of British Columbia.
San Francisco techie takes down zombie video game that let players kill homeless people: 'It showed poor judgment'
The creator said that he refunded all advertisers and made a donation to a drug treatment and recovery service equivalent to the revenue generated by the game.
Regional Science Consortium Researching Harmful Algal Blooms
If you've noticed large buoys or boats out on the bayfront and wondered what they were, you're not alone. The Regional Science Consortium is collaborating with Princeton Hydro on a research project funded by the U.S. Army Corps of Engineers to study ways to control harmful algal blooms. Dr. Jeanette Schnars, the Executive Director of the Regional Science Consortium, explained the goal of the research."We are researching different ways to control blue-green algae, which creates harmful algal blooms and releases toxins," Dr. Schnars said.The project aims to identify potential techniques for controlling harmful algal blooms in Presque Isle Bay.Schnars explained that people may notice circular floats in the water near Perry's Landing and Liberty Park. Those floats are part of the testing process."You might see a circular float, almost like a hula hoop, that is out in the bay, near Perry's Landing and Liberty Park area, and those limn corrals go all the way to the bottom. And what we will do are some treatments within the limn corral in the bottom," Schnars said.After samples are collected, they are brought back to the laboratory at the Tom Ridge Environmental Center for analysis."A lot of those samples are coming back here. We are going to test them for the harmful algal bloom toxins before, during, and after, and see how effective the testing was," Schnars said.Sarah Magyan, an aquatic biologist with the Regional Science Consortium, explained that the team also collects samples from locations throughout the region."We pull samples every week from 30 different sites, and then we bring those back here, we preserve them and run them through the ELISA test," Magyan said.Schnars said researchers hope the results will help them develop effective ways to reduce harmful algal blooms in the future."If we can do some treatments over space and time in upcoming seasons, we may be able to reduce the number of harmful algal blooms we have in this area," Schnars said.The research is also important for public and animal safety. Magyan explained that toxins produced by certain algae can affect the skin, nervous system or liver.While toxin levels may be low for people, she emphasized the importance of protecting pets that swim in local waterways."Toxins can either be skin toxins, nerve toxins, or liver toxins. While we have low levels for people, it is important that we are keeping our pets safe because we recreate with our animals in the water, and we see hundreds and hundreds of dogs on Presque Isle and the rest of the shoreline," Magyan said.Testing began in September, and Schnars said researchers expect to conduct at least another six to eight weeks of testing to better understand the effectiveness of the treatments.
Black Death had dramatic effect on species diversity as humans abandoned farmland, study finds
Researchers have found that during the Black Death, when a third of the population of Europe was wiped out, biodiversity fell. Understanding their farming practices could help us increase diversity in modern agriculture.
Leukemia That Refuses to Choose: The Science of Mixed Phenotype Acute Leukemia
A new review in Cancer Cell International synthesizes contemporary classification, clonal biology, and precision therapy for mixed phenotype acute leukemia, arguing that management must track the founding clone across phenotypic states rather than rely on static lineage labels.
‘Keep away from the doctor’: a visit to an influencer’s wellness event, where the advice could kill
Barbara O’Neill, identified as a risk to public safety in Australia, dismisses antibiotics, vaccines and scientifically proven cancer treatment at UK conference
AI-Generated Images Threaten Citizen Science Data
AI-Generated Images Threaten Citizen Science Data Experts warn AI manipulation risks distorting biological records, citing manipulated mantis and bird photos on platforms like iNaturalist
Equatorial Guinea is expanding an ambitious malaria elimination plan
Equatorial Guinea has tackled malaria with a successful strategy on Bioko Island
New Journal Charts a Technology-Driven Path Forward for Estuarine Science
A newly launched journal outlines how environmental DNA, sensor networks, artificial intelligence, and community engagement could transform the monitoring and management of the world's estuaries.
Rubio heads to Central Asia as some wonder if he\'s keeping the most pressing matters at a distance
Secretary of State Marco Rubio has left Washington on his 31st trip abroad as America’s top diplomat, heading to Uzbekistan and India amid rumblings that he’s ignoring pressing matters in
Rubio heads to Central Asia as some wonder if he's keeping the most pressing matters at a distance
Secretary of State Marco Rubio has left Washington on his 31st trip abroad as America’s top diplomat, heading to Uzbekistan and India amid rumblings that he’s ignoring pressing matters in favor of more politically safe visits and meetings.
AI Meets the Mind: How Health Data Science Is Rewiring Neuroscience and Psychology
Artificial intelligence is quietly transforming two of the most intimate fields of medicine: neuroscience and psychology. A new editorial published in Frontiers in Computational Neuroscience by Lei Lu of King's College London, Zhiqiang Huo of Queen Mary University of London,
Supporting quantitative skills in biomedical science with smart worksheets: intentions, impact and barriers to engagement
Every year, hundreds of thousands of students arrive at university with one shared weakness: the maths hiding inside their science. In biomedical science, where pipetting volumes, dilution factors, calibration curves and statistical spread underpin nearly every practical
GBIF at 25: The Open Data Machine Behind Global Biodiversity Science
Twenty-five years ago, a handful of governments bet that the fastest route to saving life on Earth ran through something unglamorous: standardized, freely shared data about where species live. That bet became the Global Biodiversity Information Facility, or GBIF, an
How Light Rewrites Skin Biology: New Research Moves Beyond Sunburn Science
A new editorial in Frontiers in Photobiology argues that skin's response to light extends far beyond sunburn and DNA damage, encompassing inflammasome-driven inflammation, visible-light pigmentation, and photochemical therapies.
They're blowing up pumpkins at Utah Tech
To celebrate National Chemistry Week, the Utah Tech University Chemistry & Biochemistry Department and Chemistry Club are teaming up to help the community learn in fun and interactive ways.
Why BioWare's Neverwinter Nights still has thousands of active players
The single-player is just OK, but according to the players, that doesn't matter.
How Tasso+ became a new obsession for testosterone-tracking biohackers
Biohackers are embracing Tasso+, a button that draws blood without a needle and measures testosterone, as the market for DIY health tracking grows.
What causes sleep paralysis; health indicators of Alzheimer's diagnosis; sober October; plus other stories with Vanderbilt Health sources
(iStock) Food and Wine interviewed Peter Martin, MD, Professor of Psychiatry and Behavioral Sciences, for a story about sober October. William Schaffner, MD, Professor of Preventive Medicine, was quoted in CNN International’s Connect the World with Becky Anderson and NewsNation Morning in America for stories about the reported plague situation in Russia, after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. Prevention interviewed James McGuirk, MD, Assistant Professor, Division of Sleep Medicine, for a story about what causes sleep paralysis. Modern Healthcare interviewed Daniel Fabbri, PhD, Associate Professor of Biomedical Informatics and Computer Science, for a story about how health systems are managing AI token costs. WNKY interviewed Ziv Beckerman, MD, Associate Chief of Pediatric Cardiac Surgery, Surgical Director of Pediatric Heart Transplantation in the Golisano Pediatric Heart Institute at Monroe Carell Jr. Children’s Hospital at Vanderbilt about rapid recovery with extended ultra oxygenated preservation (REUP) that is a new form of preservation for heart organs. Ray Romano, PhD, MPH, MSN, Nurse Practitioner, Vanderbilt Memory & Alzheimer’s Center, was quoted Prevention about research that found other health issues may be an early indicator of Alzheimer’s.
NC Life Sciences News: Labcorp’s $722M Acquisition, IQVIA’s Veeva Partnership & More
North Carolina – Regional Life Sciences Roundup -October 16th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences…
Berlin's High-End KaDeWe Store Opens Dedicated Health Hub
KaDeWe department store dedicates 2,000 square meters to training, recovery and exclusive fitness brands and includes biohacking and Lagree studio.
Business taking action for nature at CBD COP17
At the UN Biodiversity Conference (CBD COP17) in Yerevan, Armenia, from 19-30 October, IUCN will show how business can use science, data and technology to scale up its contribution to the Kunming-Montreal Global Biodiversity Framework.
Influencers and biohackers swear by fasting. Here’s what the science says.
Fasting can help some people reduce how many calories they eat — but it’s not “effortless” as some influencers would have you believe.
Plague is stoppable. The next health threat may not be.
The word plague is scary. Centuries ago, the Black Death killed tens of millions of people and changed the course of history. Plague still kills people around the world, and the word still evokes catastrophe. New fears of plague surfaced on October 2, when a lab worker in Irkutsk, Russia, died of pneumonia. Reports suggested that she may have contracted plague through a laboratory exposure. Understandably, people were alarmed. On October 7, the World Health Organization called for the Russian Federation to be transparent about what it knew. WHO issued an update on October 10. Russian authorities told WHO that testing did not identify plague and that investigations found no laboratory release. WHO said confidence in its risk assessment remained limited and that further clinical, epidemiological, and laboratory information was needed. The cause of the woman’s illness remains unknown, and WHO says a laboratory-associated exposure cannot be excluded. As I explained in a recent interview, this incident is very unlikely to lead to a pandemic. Plague is still active, including in the U.S., which sees a handful of cases each year. But it is a disease we can prevent and treat. Plague doesn’t spread readily, and it responds to antibiotics. The standard response—isolate the patient, trace contacts, and administer antibiotics and monitor for symptoms among contacts for seven days—works. We have even planned for antibiotic-resistant plague. At CDC, we developed a playbook for antibiotic-resistant plague and ran exercises on how to find and stop it. CDC guidance anticipates engineered resistance and recommends two different classes of antibiotics if there’s reason to suspect it. There is no evidence that resistance—or even confirmed plague—is involved in this incident. We have thought through how to address plague, but we’re not ready for the next major health threat that emerges from a lab or from animal spillover to humans. What should concern people is how little stands between the world and the next pathogen to get loose. Since peak COVID, epidemic preparedness has fallen off the political agenda, but the risk is greater than ever. More labs handle dangerous pathogens with more ways to make those pathogens deadlier, and more people live and work in close contact with animals. There are actions we can take now: We need better lab safety in every country. The number of labs that work with dangerous pathogens has increased worldwide over two decades, but there’s no enforceable international standard and no inspection regime; the Biological Weapons Convention, fifty years on, still has no verification mechanism. Labs that study dangerous germs need strong safety systems, training, and oversight. We need to reduce spillover events. Three in four emerging human infections start in animals, and there’s a lot we can do to reduce spillover risk, but the world is doing very little of it. Live-animal markets are one place to act. For instance, closing live-bird markets helped control H7N9 influenza in China. Reducing opportunities for people to encounter infected animals can prevent infections before they become outbreaks. In The Formula for Better Health, which is now out in paperback along with the hardcover, Kindle, and audiobook versions, I argue that labs do too many risky experiments with too many dangerous pathogens in too many institutions, and that every experiment should first answer one basic question: Is the likely benefit greater than the risk? Spillover risk can also be reduced: In the book, I discuss how Brazil cut its deforestation rate by 70% from 2004 to 2012 while increasing agricultural production and reducing risky contact between people and forest animals. We need faster detection and response. Delay costs lives. Strong surveillance, good labs, and trained responders can turn a single case into a small cluster of infections instead of an epidemic. Resolve to Save Lives has worked for nearly a decade to help countries find and stop outbreaks faster. The 7-1-7 target, which Resolve to Save Lives developed with partners in Uganda and elsewhere, provides a clear standard: detect within 7 days, notify within 1 day and complete all essential early response actions within 7 days. In Uganda’s Kasese district, for example, a review of a measles outbreak using 7-1-7 identified shortages of accessible funds, fuel, and vehicles that delayed the response. District leaders established funds they could access quickly. When, a few months later, the Crimean-Congo hemorrhagic fever appeared, the district detected it in three days, notified authorities in one, and mounted an effective response in two. Only one case was confirmed, and the patient survived. Because funds were available before the emergency, authorities were prepared and able to act. This kind of preparation can’t wait until the next crisis begins. Plague is an old disease we that know how to stop. The next threat may be harder to recognize, harder to treat, and easier to spread. Safer labs, less risk of spillover, and faster outbreak detection and response need sustained investment now, while we still have time to prevent the next emergency. Share
Rice graduate students showcase innovative research at synthetic biology science cafe
The Science and Technology Policy Program at Rice’s Baker Institute for Public Policy hosted a “science cafe” Oct. 13 to bring research to reality and answer questions from the public, giving attendees a look at projects underway in university laboratories and an opportunity to ask questions about the science, its potential applications and its implications for society.
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
A Good Gut Feeling Starts with Strong Science
Digestive health is evolving beyond basic gut support as consumers increasingly connect the microbiome to broader wellness goals
'Jeff Corwin’s Southern Wild' episode features Pamlico County
The second episode of biologist Jeff Corwin's new television series "Jeff Corwin's Southern Wild," titled "Wildlife After Dark," features a segment on red drum research, a protected game fish and
Wildlife biologist launches bear-proofing business to help LA County homeowners
Wildlife biologist creates bear-proofing business to help SoCal residents
Scientists discover a plastic-eating “Pac-Man” enzyme with a surprising secret
Scientists have discovered a remarkable “Pac-Man enzyme” that helps bacteria devour certain types of plastic and may offer new hope in the fight against plastic pollution. Researchers found that several biodegradable plastics completely broke down in soil within about a year, while conventional plastic remained largely unchanged.
SMC's Distinguished Scientists Series Returns: Biotech & USC Talks
Free science lectures at Santa Monica College on Oct. 20 and Nov. 19 featuring biotech executives and USC researchers discussing precision medicine and gene therapy.
Why Science Communication Is Breaking Down, and How Philanthropy Can Fix It
A Milken Institute team argues that the biomedical communication pipeline is breaking down at publication, distribution, and public engagement, and that philanthropy is uniquely positioned to repair it.
AstraZeneca - How is AI helping scientists design the next generation of biologic medicines?
Learn how AstraZeneca combines AI drug discovery, laboratory automation and biology to refine biologic molecules and inform earlier decisions.
Kalamazoo County health officials say, "get your flu shot... as soon as possible"
WWMT-TV Newschannel 3 provides local news, weather forecasts, notices of events and entertainment programming for Kalamazoo, Grand Rapids, Battle Creek, South Haven, Paw Paw, Portage, Otsego, Texas Township, Oshtemo, Plainwell, Allegan, Holland, Saugatuck, Holland, Wayland, Kentwood, Middleville, Hastings, Marshall, Three Rivers, Sturgis, Constantine, Coldwater, Albion, Wyoming, Hudsonville, Allendale, Byron Center, Hudsonville, Grand Haven, Muskegon, Sparta, Rockford, Belding, Greenville, Ionia, Cedar Springs and their surrounding areas.
Labcorp to Acquire Select BioReference Health Assets for $722M
Labcorp to acquire select BioReference Health assets from OPKO Health for $722 million, including labs, service centers, and a prostate test.
Gut health may affect more than digestion, doctor says
A diverse gut microbiome can influence digestion, immune function and the body’s communication with the brain, pathologist Dr. Ryan Cole said in an interview with The National News Desk.
Biola University Opens Snyder School of Cinema & Media Arts
Biola University's new building for the Snyder School of Cinema & Media Arts opens Thursday, ushering in a stocked with the latest technology.
Moisés Expósito-Alonso receives Packard Fellowship
The David and Lucile Packard Foundation announced today that UC Berkeley integrative biology professor Moisés Expósito-Alonso will receive one of its prized Packard Fellowships for Science and
NEWS: Biomedical Studies, NSF-Funded Science, Student-Led Projects, and More on NASA’s SpaceX CRS-35
ISS National Lab-sponsored research aims to advance regenerative medicine, improve understanding of natural hazards, and inspire the next generation of scientists and explorers
Labcorp to Acquire Select Assets of BioReference Health for $722M
Labcorp will acquire BioReference's lab businesses focused on clinical and women's health testing, urology, and corrections as well as its 4Kscore prostate cancer blood test.
Opko Health stock soars on $722M BioReference asset sale
Investing.com -- Opko Health Inc (NASDAQ:OPK) shares surged 20% in premarket trading Thursday after Labcorp Holdings Inc (NYSE:LH) agreed to acquire select assets of BioReference Health for $722 million in cash.
How lost fibre in sugar impacts health and how we can get it back
The loss of fibre in sugar has led to numerous diseases; the solution may lie in redesigning food and restoring beneficial biological signals.
Computational Models as Liminal Models in Neuroscience, a Cognitive Science Speaker Series Presentation | Events
Speaker: Danielle Williams, Ph.D. Title: Computational Models as Liminal Models in Neuroscience Short Bio: Danielle is a philosopher of mind and science whose research examines the role of computation in our theories and explanations of the mind and brain. Her work brings together philosophy of mind, cognitive science, neuroscience, and artificial intelligence, with particular interests in computational theories of mind, computational modeling, and the relationship between different explanatory and modeling strategies in the mind sciences. She also investigates philosophical questions raised by contemporary AI, including the nature of opacity in computational models and its implications for explanation in cognitive science. Alongside this work, she is a historian of cognitive science and AI, examining how the development of computer technology has shaped our conceptions and models of the mind and brain. Abstract: Scientists rely on various types of models to make sense of their phenomena of interest. This has led philosophers to take up a range of semantic, ontological, and epistemological questions about how models represent, what kinds of things models are, what we learn from models, and how they explain. One type of model that has been of particular interest to philosophers is the computational model. Computational models are commonplace in the mind sciences in general and neuroscience in particular, with many asking how computational modeling can help us understand the nervous system and its contribution to cognition and behavior. These questions are particularly pressing in neuroscience, as computational models have become a dominant framework for making sense of cognition. Thus, old questions about model-based science have re-emerged within the context of neuroscience, with many philosophers looking to established frameworks to understand how computational models represent, explain, and contribute to theory development in neuroscience. These established frameworks, however, characterize computational models as a homogeneous type which cannot capture actual modeling practices in neuroscience. In this talk, I argue that computational models in neuroscience are best typed as a kind of liminal model, a type I introduce to capture how the status of a computational model is determined by the epistemic context in which it is deployed. Indeed, the category to which a computational model belongs shifts according to the role it plays within a given context. ASL-English interpreters have been requested. Light refreshments will be provided.